Tumors that develop in the nervous system such as schwannomas and glioblastoma multiforme (GBM) are very difficult to treat. With very few or no effective pharmacological options, patients undergo repeated surgeries to remove or debulk the tumors. New targets for the development of safe and effective therapies to treat these tumors are desperately needed. We and others have shown that solid tumors present high levels of protein tyrosine nitration, an oxidative post-translational modification that occurs in pathological conditions involving oxidative stress. Here we show nitrated proteins regulate survival and migration of GBM cells and identify the subcellular location of our first nitrated target that has tumorigenic activity. We recently uncovered nitrated proteins regulate schwannoma cell metabolism and support cell survival. Among the identified nitrated proteins in human schwannomas, the chaperone Heat shock protein 90 (Hsp90), when nitrated, downregulates mitochondrial activity and supports tumor cell survival. Furthermore, nitration of Hsp90 induces a position-dependent gain-of-function. While nitration on tyrosine 33 (3NT33) leads to the downregulation of mitochondrial activity, nitration on tyrosine 56 (3NT56) activates the P2X7 receptor, which has been linked to increased glycolysis in tumors. Decreased mitochondrial activity and increased glycolysis is a hallmark of many tumor metabolic phenotypes, known as the Warburg effect. Nitrated Hsp90 can therefore play a key tumorigenic role by acting as a metabolic switch. To study the role of nitrated proteins in GBM, we developed 2D and 3D cell culture models by growing human U87 cells as a monolayer or allowing them to form tumoroids which express stem cell markers such as Nestin, SOX1, and SOX2. We found that preventing tyrosine nitration using complementary methodologies decreased cell survival and regulated U87 cell migration. Treatment of cells with antioxidants that prevent tyrosine nitration such as urate and edaravone significantly decreased cell survival in low density 2D cultures, while almost completely inhibited the ability of the cells grown at high density to form 3D tumoroids. These results were confirmed in transmigration assays using conditioned media from tumoroid cultures as chemoattractant and high-content imaging. In tumoroids, the nitration state of Hsp90 had a substantial effect on its subcellular localization. We developed monoclonal antibodies that specifically recognize Hsp90(3NT33) and Hsp90(3NT56). Confocal microscopy using these antibodies revealed that Hsp90(3NT33) localized in mitochondria and cytosol but not in the nucleus in the layer of cells on the surface of the tumoroids, and in cells surrounding them, but was almost undetectable in the tumoroid's core. In contrast, Nitrated Hsp90(3NT56) also localized in the nucleus and was homogenously distributed throughout the surface and core of tumoroids. These results suggest that differential nitration states of Hsp90 and/or other nitrated proteins may play a fundamental role in GBM cell survival and migration, posing nitrated Hsp90 and possibly other nitrated proteins as a promising new category of tumor-directed targets.
Read full abstract